Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
Miguel Brito, Research Coordinator at H&TRC – Health and Technology Research center, shared post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Highlights
Newborn screening of 13,000+ infants in Luanda, Angola, identified a sickle cell disease prevalence of 1.38%.
Sickle cell trait was common, affecting 20.31% of screened newborns.
Follow-up of diagnosed patients is challenging due to low disease literacy and socioeconomic barriers.
With: Catarina Ginete , Baba Inusa, Jocelyne Neto de Vasconcelos NBS and paper with the support of Arise Initiative.
And the support of Revvity for Diagnostics and H&TRC – Health and Technology Research Center”
Title: Newborn screening for sickle cell disease in Angola: Implementation challenges and emerging data on hemoglobinopathy prevalence
Authors: Miguel Brito, Catarina Ginete, Mariana Jacinto, Manuela Mendes, Hailton Soares, Roberto Afonso, Adriano Siatembo, Jocelyne Vasconcelos, Baba Inusa
Read the Full Article on Blood Cells, Molecules and Diseases

Stay updated with Hemostasis Today.
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies